BATE KENNETH received a stock award from MADRIGAL PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/24/2025ACC: 0001628280-25-032863
Director
Since Jun 2019
+2K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+715.00
Price / share
—
Trade value
—
% of position
37.4%
6/20/2025
1.91K→2.63K
Total
Net shares
+715.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/20/2025 | A · Award | +715.00 | — | — | 37.4% | 1.91K | 2.63K |
| Total | +715.00 | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.29K shares
Shares
+1.29K
Strike price
285.73
Held after
1.29K
Exercisable
—
6/20/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.29K shares | 6/20/2025 | A · Award | +1.29K | 285.73 | — | 1.29K |